• 1

    Murabito JM, D’Agostino RB, Silbershatz H, Wilson WF: Intermittent claudication: a risk profile from the Framingham Heart Study. .Circulation 96::44. –49,1997.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Hiatt WR: Medical treatment of peripheral arterial disease and claudication. .N Engl J Med 344::1608. –1621,2001.

  • 3

    Criqui MH: Peripheral arterial disease: epidemiological aspects. .Vascular Medicine 6: (Suppl. 1):3. –7,2001.

  • 4

    Bernstein EF, Fronek A: Current status of noninvasive tests in the diagnosis of peripheral arterial disease. .Surg Clin North Am 62::473. –487,1982.

  • 5

    Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. .Practical Diabetes Int 16::163. –166,1999.

    • Search Google Scholar
    • Export Citation
  • 6

    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. .JAMA 286::1317. –1324,2001.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. .Circulation 94::3026. –3049,1996.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Concensus (TASC). .J Vasc Surg 31::S1. –S296,2000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM: Peripheral artery disease, diabetes, and reduced lower extremity functioning. .Diabetes Care 25::113. –120,2002.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    McDaniel MD, Cronenwett JL: Basic data related to the natural history of intermittent claudication. .Ann Vasc Surg 3::273. –277,1989.

  • 11

    Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. .JAMA 287::2570. –2581,2002.

  • 12

    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. .Circulation 97::425. –428,1998.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. .Diabetes 47::457. –463,1998.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. .Diabetologia 45::623. –634,2002.

  • 15

    Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP: Nitric oxide regulates monocyte chemotactic protein-1. .Circulation 96::934. –940,1997.

  • 16

    Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. .Arterioscler Thromb Vasc Biol 22::1370. –1380,2002.

  • 17

    Schneider DL, Sobel BE: Diabetes and thrombosis. In Diabetes and Cardiovascular Disease. Johnstone MT, Veves A, Eds. Totowa, NJ, Humana Press. ,2001.

  • 18

    American Diabetes Association: Preventive foot care in people with diabetes (Position Statement). .Diabetes Care 26: (Suppl. 1):S78. –S79,2003.

  • 19

    Strandness DE Jr, Bell JW: Peripheral vascular disease: diagnosis and evaluation using a mercury strain gauge. .Ann Surg 161: (Suppl. 4):1. –35,1965.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Lassila R, Lepantalo M: Cigarette smoking and the outcome after lower limb arterial surgery. .Acta Chir Scand 154::635. –640,1988.

  • 21

    UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). .Lancet 352::837. –853,1998.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Stokes J, Kannel WB, Wolf PA, Cupples LA, D’Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. .Circulation 75::V65. –V73,1987.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). .BMJ 317::703. –713,1998.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. .N Engl J Med 342::145. –153,2000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Leng GC, Price JF, Jepson RG: Lipid-lowering for lower limb atherosclerosis (Cochrane Review). .Cochrane Database Syst Rev 2::CD000123. ,2000.

    • Search Google Scholar
    • Export Citation
  • 26

    Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). .Lancet 344::1383. –1389,1994.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Kjekshus J, Pedersen TR: Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). .Am J Cardiol 76::64C. –68C,1995.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. .Lancet 360::7. –22,2002.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Antiplatelet Trialists’ Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. .Br Med J 308::81. –106,1994.

    • Search Google Scholar
    • Export Citation
  • 30

    American Diabetes Association: Aspirin therapy in diabetes (Position Statement). .Diabetes Care 26: (Suppl. 1):S87. –S88,2003.

  • 31

    CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). .Lancet 348::1329. –1339,1996.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Larsen OA, Lassen NA: Effect of daily muscular exercise in patients with intermittent claudication. .Lancet 2::1093. –1096,1966.

  • 33

    Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication (Cochrane Review). .Cochrane Database Syst Rev 2::CD000990. ,2000.

  • 34

    Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR: Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. .J Am Geriatr Soc 50::1939. –1946,2002.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE: A comparison of cilostazol and pentoxifylline for treating intermittent claudication. .Am J Med 109::523. –530,2000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Kannel WB, Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. .J Cardiovasc Risk 1::3333. –3339,1994.

    • Search Google Scholar
    • Export Citation
  • 37

    American Diabetes Association: Diabetic foot wound care (Consensus Statement). .Diabetes Care 21::1354. –1360,1999.

Peripheral Arterial Disease in People with Diabetes

Restricted access

Address correspondence to: Nathaniel Clark, MD, MS, RD, American Diabetes Association, 1701 N Beauregard St, Alexandria, VA 22311 (e-mail: nclark@diabetes.org).